Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule

C. Sessa, K. Weigang-Köhler, O. Pagani, G. Greim, O. Mor, T. De Pas, M. Burgess, I. Weimer, R. Johnson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule'. Together they form a unique fingerprint.

Medicine & Life Sciences